Latest news
-
-
August 31, 2023
Almac expands Next Generation Sequencing capabilities through investment in new Illumina NovaSeq™ X Plus instrument
-
May 17, 2023
Almac Diagnostic Services updates claraᵀ report with significant new content for cancer research
-
August 11, 2022
Almac, AstraZeneca CDx Partnership Branching Out to New Disease Areas, Drawing on NGS, qPCR
-
June 23, 2022
Almac Diagnostic Services collaborates with AstraZeneca to Develop and Commercialize Companion Diagnostics (CDx)
-
December 8, 2021
Almac Diagnostic Services’ claraT Report Assists Researchers In Uncovering New Oncology Findings
-
October 7, 2021
Dr Richard Turkington Joins Almac Diagnostic Services to Support Biomarker Research
-
January 11, 2021
Personal Genome Diagnostics and Almac Diagnostic Services Enter Strategic Collaboration to Enhance Patient Care in Oncology
-
July 21, 2020
Almac Group Announces Winners of claraT Grant Program for Academia